FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 1996 EDITEK, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-11394 95-3863205 (Commission File Number) (IRS Employer Identification No.) 1238 Anthony Road Burlington, North Carolina 27215 (Address of principal executive offices) (Zip Code) (910) 226-6311 (Registrant's telephone number, including area code) Item 5. Other Events. On June 5, 1996, the Board of Directors of the Registrant formed an Executive Committee of the Board of Directors comprised of the Registrant's four outside Directors, Robert J. Beckman, Gene E. Lewis, George W. Masters, and Samuel C. Powell, Ph.D. The Members of the Executive Committee will serve as the Office of the Chairman of the Registrant. James D. Skinner will continue as President and Chief Executive Officer of the Registrant and will have a special assignment relative to the Registrant's North Carolina operations. Harry G. McCoy, Pharm.D. will be responsible for MEDTOX, and Peter J. Heath will continue his responsibilities as Chief Financial Officer. These three individuals will all report to the Office of the Chairman. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EDITEK, INC. Date: June 14, 1996 By:/s/ Peter J. Heath Name: Peter J. Heath Title: Vice President of Finance and Chief Financial Officer